ANVISA-2020-0085-V185

Type II variation for application ANVISA-2020-0085. Type II variation: Labeling Change for Immunovant-α — minor update

Variation Number
ANVISA-2020-0085-V185
Type
Type II
Application
ANVISA-2020-0085
Change
CHG-2024-0185
Status
Blocked
Fee
€38,092
Submitted
2023-10-15
Approved
—
Description

Type II variation: Labeling Change for Immunovant-α — minor update